RGNX
Price
$10.08
Change
-$0.05 (-0.49%)
Updated
Jun 4 closing price
Capitalization
505.62M
55 days until earnings call
VYGR
Price
$3.32
Change
+$0.04 (+1.22%)
Updated
Jun 4 closing price
Capitalization
183.72M
56 days until earnings call
Interact to see
Advertisement

RGNX vs VYGR

Header iconRGNX vs VYGR Comparison
Open Charts RGNX vs VYGRBanner chart's image
REGENXBIO
Price$10.08
Change-$0.05 (-0.49%)
Volume$690.26K
Capitalization505.62M
Voyager Therapeutics
Price$3.32
Change+$0.04 (+1.22%)
Volume$1.01M
Capitalization183.72M
RGNX vs VYGR Comparison Chart
Loading...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RGNX vs. VYGR commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGNX is a Hold and VYGR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (RGNX: $10.08 vs. VYGR: $3.32)
Brand notoriety: RGNX and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RGNX: 61% vs. VYGR: 203%
Market capitalization -- RGNX: $505.62M vs. VYGR: $183.72M
RGNX [@Biotechnology] is valued at $505.62M. VYGR’s [@Biotechnology] market capitalization is $183.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGNX’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • RGNX’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, both RGNX and VYGR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RGNX’s TA Score shows that 5 TA indicator(s) are bullish while VYGR’s TA Score has 6 bullish TA indicator(s).

  • RGNX’s TA Score: 5 bullish, 3 bearish.
  • VYGR’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than RGNX.

Price Growth

RGNX (@Biotechnology) experienced а +11.14% price change this week, while VYGR (@Biotechnology) price change was +21.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.56%. For the same industry, the average monthly price growth was +5.22%, and the average quarterly price growth was -1.09%.

Reported Earning Dates

RGNX is expected to report earnings on Jul 30, 2025.

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($506M) has a higher market cap than VYGR($184M). RGNX YTD gains are higher at: 30.401 vs. VYGR (-41.446). VYGR has higher annual earnings (EBITDA): -97.25M vs. RGNX (-198.23M). VYGR (236M) and RGNX (235M) have equal amount of cash in the bank . VYGR has less debt than RGNX: VYGR (42M) vs RGNX (82M). RGNX has higher revenues than VYGR: RGNX (83.3M) vs VYGR (67M).
RGNXVYGRRGNX / VYGR
Capitalization506M184M275%
EBITDA-198.23M-97.25M204%
Gain YTD30.401-41.446-73%
P/E RatioN/A6.00-
Revenue83.3M67M124%
Total Cash235M236M100%
Total Debt82M42M195%
FUNDAMENTALS RATINGS
RGNX vs VYGR: Fundamental Ratings
RGNX
VYGR
OUTLOOK RATING
1..100
777
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9591
PRICE GROWTH RATING
1..100
4390
P/E GROWTH RATING
1..100
2010
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (35) in the Biotechnology industry is somewhat better than the same rating for RGNX (74). This means that VYGR’s stock grew somewhat faster than RGNX’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RGNX (100). This means that VYGR’s stock grew similarly to RGNX’s over the last 12 months.

VYGR's SMR Rating (91) in the Biotechnology industry is in the same range as RGNX (95). This means that VYGR’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's Price Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for VYGR (90). This means that RGNX’s stock grew somewhat faster than VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (10) in the Biotechnology industry is in the same range as RGNX (20). This means that VYGR’s stock grew similarly to RGNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RGNXVYGR
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 16 days ago
75%
Bullish Trend 17 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WAUSX14.840.23
+1.57%
Wasatch US Select Investor
EKWYX91.96N/A
N/A
Allspring Precious Metals Inst
VRNIX524.94N/A
N/A
Vanguard Russell 1000 Index I
DAFGX39.89N/A
N/A
Dunham Focused Large Cap Growth A
TSOEX14.91N/A
N/A
Nuveen International Res Eq Retire

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+1.22%
RGNX - VYGR
52%
Loosely correlated
-0.49%
TRDA - VYGR
51%
Loosely correlated
-3.76%
KYMR - VYGR
51%
Loosely correlated
+1.56%
XNCR - VYGR
48%
Loosely correlated
-0.44%
IMNM - VYGR
48%
Loosely correlated
-2.59%
More